|
Search
Collections
Benchmarks
Upload document
DeltaRex-G Plus
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 abstract
Abstract
Effect of DeltaRex-G ± DeltaRex-G Plus (an FDA-approved drug) on advanced chemoresistant pancreatic cancer, sarcoma, and breast cancer.
Org:
William H. Isacoff, MD, Inc,
